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a b s t r a c t
Mitochondrial toxicity is increasingly being implicated as a contributing factor to many xenobiotic-
induced organ toxicities, including skeletal muscle toxicity. This has necessitated the need for predictive
in vitro models that are able to sensitively detect mitochondrial toxicity of chemical entities early in the
research and development process. One such cell model involves substituting galactose for glucose in the
culture media. Since cells cultured in galactose are unable to generate sufﬁcient ATP from glycolysis they
are forced to rely on mitochondrial oxidative phosphorylation for ATP generation and consequently are
more sensitive to mitochondrial perturbation than cells grown in glucose. The aim of this study was to
characterise cellular growth, bioenergetics and mitochondrial toxicity of the L6 rat skeletal muscle cell
line cultured in either high glucose or galactose media. L6 myoblasts proliferated more slowly when
cultured in galactose media, although they maintained similar levels of ATP. Galactose cultured L6 cells
were signiﬁcantly more sensitive to classical mitochondrial toxicants than glucose-cultured cells,
conﬁrming the cells had adapted to galactose media. Analysis of bioenergetic function with the XF
Seahorse extracellular ﬂux analyser demonstrated that oxygen consumption rate (OCR) was signiﬁcantly
increased whereas extracellular acidiﬁcation rate (ECAR), a measure of glycolysis, was decreased in cells
grown in galactose. Mitochondria operated closer to state 3 respiration and had a lower mitochondrial
membrane potential and basal mitochondrial O2d– level compared to cells in the glucose model. An
antimycin A (AA) dose response revealed that there was no difference in the sensitivity of OCR to AA
inhibition between glucose and galactose cells. Importantly, cells in glucose were able to up-regulate
glycolysis, while galactose cells were not. These results conﬁrm that L6 cells are able to adapt to growth
in a galactose media model and are consequently more susceptible to mitochondrial toxicants.
& 2014 The Authors. Published by Elsevier B.V. All rights reserved.
Introduction
Skeletal muscle accounts for around 45% of total body weight
and is characterised by a high rate of blood ﬂow. Consequently, it
is highly exposed to circulating xenobiotics [24]. In addition,
skeletal muscle is one of the most metabolically active tissues,
along with the heart and liver, and so requires a large amount of
mitochondria for ATP production, making it particularly prone to
xenobiotic-induced mitochondrial toxicity [12,23]. Indeed,
research has shown that mitochondrial toxicity plays an impor-
tant role in a number of xenobiotic-induced skeletal muscle
myopathies, including antiretroviral (zidovudine) [35] and statin
[20,2] myotoxicity. Notably, cerivastatin was withdrawn from the
market in 2001 due to over 100 rhabdomyolysis-related deaths
[6]. In this instance, skeletal muscle toxicity and mitochondrial
perturbation was not identiﬁed during preclinical in vitro or
in vivo screening and was only observed after the drug was in
the market [20].
It is therefore important that high-throughput assays are
implemented early in the research and development process
which can effectively detect xenobiotics that impair mitochondrial
function. One model that has been developed to improve detection
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of mitochondrial toxicants utilises cells grown in two types of
media, one supplemented with high glucose (25 mM) and the
other with galactose [22]. Cells grown in high glucose media are
able to compensate for mitochondrial impairment by utilising
glycolysis for ATP generation, and therefore, are more resistant to
mitochondrial toxicities. In contrast, cells grown in galactose as
the sole sugar are forced to rely on mitochondrial oxidative
phosphorylation (OXPHOS) to meet their energy requirements
[30,15]. This is due to the slow metabolism of galactose to
glucose-1-phosphate, which means that cells grown in galactose
likely derive a majority of their ATP from glutamine (if present in
the media) metabolism [29,38]. For example, it has been shown
that HeLa cells derive 98% of their ATP from glutamine when
cultured in galactose [29]. Since cells cultured in galactose (sup-
plemented with glutamine) rely mostly on OXPHOS to produce
their ATP, they become more sensitive to mitochondrial toxicants
than cells grown in high glucose [22,11]. This model has been
successfully used in liver (HepG2) and cardiac (H9c2) cell lines to
identify mitochondrial toxicants [22,11,27]. However, to date, it
has not been evaluated in a skeletal muscle cell line to assess
mitochondrial toxicity.
The ability to alter the energy metabolism using this model
has also been employed to identify cells with disease states
that have underlying mitochondrial liabilities [30,1]. In addi-
tion, it has been used as a method to discover compounds that
drive energy metabolism from mitochondrial respiration to
glycolysis [15]. For example, Gohil et al. [15] demonstrated that
compounds that are able to switch metabolism may have thera-
peutic potential, since they are able to suppress mitochondrial
function and thereby minimise oxidative damage that follows
ischaemic injury.
Studies have shown that a number of different cell types (e.g.
cancer cells, ﬁbroblasts and myotubes) are able to adapt to growth
in galactose media and consequently show a signiﬁcantly
increased oxygen consumption rate and decreased glycolytic rate
compared to cells cultured in high glucose [33,22,1,9]. Since the L6
rat skeletal muscle cell line is widely used as an in vitro model of
skeletal muscle [34,18,17], it is potentially an ideal model for
identifying mitochondrial toxicities. However, it is not currently
known if this cell line is able to adapt to growth in galactose media
and subsequently adapt its bioenergetic function as previously
described for other cell types. Therefore, in this study we have
characterised the effect of replacing glucose with galactose in the
media on growth patterns, ATP synthesis capacity and bioener-
getic function in the L6 skeletal muscle cell line. We also used
classical inhibitors of the mitochondria to further investigate
changes in mitochondria function following a switch to galactose
media and the mechanism underlying the increased sensitivity of
galactose cultured L6 cells to mitochondrial toxicity.
Materials and methods
Materials
The L6.G8.C5 (L6 subclone) cell line was provided by Alan
Bevington (University of Leicester). The H9c2 and HepG2 cell
lines were purchased from the American Type Cell Collection
(ATCC). All chemicals were supplied by Sigma-Aldrich unless
otherwise stated. MitoSox™, MitoTrackers Red CMXRos and ATP
determination kit were purchased from Molecular Probes, Inc.,
Life Technologies UK Ltd. All materials and reagents for the
Extracellular Flux assays were from Seahorse Biosciences (North
Billerica, MA).
Cell culture conditions
High glucose media
The high-glucose media consisted of Dulbecco0s modiﬁed
Eagle0s medium (DMEM) (Invitrogen), containing 25 mM glucose
and 1 mM sodium pyruvate and supplemented with 5 mM N-2-
hydroxyethylpiperazine-N0-2-ethanesulfonic acid (HEPES), 10%
FBS, and penicillin–streptomycin (pen–strep; 500 Lg/ml).
Galactose media
The galactose media consisted of DMEM without glucose
(Invitrogen) supplemented with 10 mM galactose, 2 mM gluta-
mine (6 mM ﬁnal), 5 mM HEPES, 10% FBS, 1 mM sodium pyruvate,
and pen–strep as above.
HepG2, H9c2 and L6 cells (ATCC) were grown in either glucose
or galactose-containing media (15 ml) and maintained in 5% CO2 at
37 1C. Cells were maintained in 75 cm2 ﬂasks and subcultured with
trypsin when cells reached 70–80% conﬂuency.
Cell counting
At each subculture, the cells were stained with trypan blue and
counted using a haemocytometer. The population doubling (PD)
and doubling time (DT) were calculated using the following
formula:
PD¼ ðlog 10Y log 10ZÞ= log 10ð2Þ
DT ¼ TðhÞlog 10ð2Þ=ðlog 10Y=log 10ZÞ
(Y indicates the number of cells harvested; Z indicates the number
of cells seeded; T (h) indicates time in hours.) Cumulative popula-
tion doublings (CPD) were calculated as the sum of the PD with
every successive passage.
Measurement of cellular ATP content
L6, H9c2 and HepG2 cells were seeded at a density of 10,000,
7500 and 20,000 cells/well, respectively, in a white 96-well plate
with a clear bottom in 200 μl of media. The plates were incubated
in a 37 1C humidiﬁed incubator with 5% CO2 for 24 h to reach
70–80% conﬂuency. Cellular ATP concentrations were assessed using
the ATP Determination kit as instructed in the manufacturer0s proto-
col. Luminescence was measured using a NOVOstar luminometer at
28 1C. For compound treatments, the compound stock solutions were
prepared in 1% DMSO and added to the wells to give the indicated
ﬁnal compound concentrations. Compounds were added 24 h before
measurements.
Detection of mitochondrial O2
–
MitoSOXTM red was used in live cells. L6 cells were seeded into
6-well plates at 2105 cells/well and grown to 70–80% conﬂu-
ence. MitoSox was added to a ﬁnal concentration of 5 μM 30 min
prior to the end of the treatment period and cell ﬂuorescence was
measured on a CyAn ADP ﬂow cytometer (excitation: 488 nm;
emission: 578 nm). Data were also collected in FSC (forward
scatter) and SSC (side scatter) and a total of 10,000 events were
collected for each sample.
Measurement of mitochondrial membrane potential
Mitochondrial membrane potential was measured using Mito-
Tracker Red CMXRos (500 nM) in live cells using a CyAn ADP ﬂow
cytometer (excitation: 488 nm; emission: 578 nm). Data were also
collected in FSC (forward scatter) and SSC (side scatter) and a total
of 10,000 events were collected for each sample.
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Measurement of L6 mitochondrial bioenergetics using the Seahorse
XF24-extracellular ﬂux analyzer
An XF24 Analyzer (Seahorse Biosciences, North Billerica MA)
was used to measure bioenergetic function in intact L6 cells in real
time. L6 cells were seeded into Seahorse Bioscience XF24 cell
culture plates to the indicated density in 250 μl media and allowed
to adhere and grow for 24 h in a 37 1C humidiﬁed incubator with
5% CO2. Measurements of extracellular ﬂux were made in unbuf-
fered media. For these experiments, the media was changed 1 h
prior to the start of the extracellular ﬂux assay to unbuffered (pH
7.4) DMEM containing 2 mM GlutaMax, 1 mM sodium pyruvate
and supplemented with 25 mM glucose or 10 mM galactose and
incubated at 37 1C without CO2. Normalisation to total protein
content in the well following the experiment was used to control
for variation in cell number between glucose and galactose
cultured cells. On completion of the XF assay, the cells were lysed
with CellLytic MT lysis reagent (200 μl/well) and protein concen-
tration determined using the Bradford reagent. The protein con-
centration of a sample was derived by reference to a bovine serum
albumin (BSA) standard curve. The OCR data were expressed as
pmol/min/mg protein and ECAR as mpH/min/mg protein.
Mitochondrial function of L6 cells cultured in glucose and
galactose media was analysed by sequentially adding pharmaco-
logical inhibitors of oxidative phosphorylation [10]. The resultant
bioenergetic proﬁle (Fig. 1) provides detailed information on the
individual components of the respiratory chain. For a detailed and
extensive review on the interpretation of the bioenergetic proﬁle,
please refer to Hill et al. [16]. Brieﬂy, six parameters of mitochon-
drial function were calculated from the bioenergetic proﬁle: basal
OCR, ATP-inked OCR, proton leak OCR, maximal OCR, reserve
capacity and non-mitochondrial OCR (Fig. 1). These parameters
of mitochondrial function were used to derive the respiratory ﬂux
control ratios: coupling efﬁciency, respiratory control ratio (RCR),
Stateapparent and phosphorylating respiration. State apparent is
used to determine the apparent respiratory state of the cells.
As suggested by other studies, it is unlikely that the classical state
3 (ADP and substrate are not limited and respiration is maximum)
or state 4 (ADP reaches equilibrium and respiration slows),
observed in isolated mitochondria [4], are replicated in intact cells.
Instead an intermediate turnover state, known as State 3.5 (the
Stateapparent) has been proposed for intact cells [10]. In these
experiments, the assumption is made that state 3 respiration is
equivalent to the rate measured after addition of FCCP (‘state 3FCCP’
or ‘state 3u’) and state 4 is the rate measured after addition of
oligomycin (‘state 4oligomycin’ or ‘state 4o’). These assumptions allow
for calculation of the apparent respiratory state of the cells using
the following equation:
Stateapparent ¼ 4ðBasalOligoÞ
ðFCCP–OligoÞ
where ‘Basal’ represents the basal OCR, ‘Oligo’ represents the
oligomycin-insensitive OCR (proton leak) and ‘FCCP’ represents
the FCCP-stimulated OCR (maximal OCR). Using the same assump-
tions regarding the relative state 3 and state 4 respiration, the
respiratory control ratio (RCR) can be calculated as the state 3u rate
divided by state 4o rate (maximal OCR/oligomycin-insensitive OCR).
RCR indicates the tightness of the coupling between respiration and
oxidative phosphorylation and is sensitive to changes in substrate
oxidation and proton leak, but not ATP turnover [4]. Coupling
efﬁciency is the proportion of the oxygen consumed to drive ATP
synthesis compared with that driving proton leak and is calculated
as the fraction of basal mitochondrial OCR used for ATP synthesis
(ATP-linked OCR/basal OCR) [4]. Finally, the fraction of respiration
that is used under routine conditions to produce ATP (phosphor-
ylating respiration) was estimated as the ratio between ATP-linked
OCR and maximal OCR (FCCP) (ATP-linked OCR/Maximal OCR),
as described in Domenis et al. [9].
Statistical analysis
All data are presented as mean and standard error of the mean
(SEM) or standard deviation (SD) as appropriate. Statistical ana-
lyses were performed using Graphpad Prisms 6 software (Graph-
Pad Software, Inc., La Jolla, CA, USA). Statistical signiﬁcance of the
data was assessed by paired Student0s t-test, one-way Analysis of
Variance (ANOVA) (with Dunnett0s multiple comparison test)
or two-way ANOVA (with Sidak0s or Tukey0s multiple comparison
test) as appropriate. A P-value of o0.05 was considered
statistically signiﬁcant. IC50 values were calculated in Graphpad
Prism using a nonlinear regression curve ﬁt with 4 parameters.
The maximum (DMSO control) and minimum values (total cell kill)
were ﬁxed.
Results and discussion
Maintenance of cell growth in galactose media
A number of cell types, including H9c2 and HepG2, have
previously been shown to successfully adapt to galactose media
[22,27] with 7 days sufﬁcient for cells to adjust their cellular
bioenergetics (i.e. an increase in OXPHOS) [15,1,37,9]. Cryopre-
served L6, H9c2 and HepG2 cells previously grown in high glucose
media were thawed and grown for a minimum of 7 days in either
high glucose (25 mM) or galactose (10 mM) media. No signiﬁcant
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Fig. 1. Representative OCR proﬁle of the mitochondrial function assay using L6 cells
cultured in glucose media. The example is from control L6 cells cultured in glucose.
Baseline OCR was measured 3 times for 3 min each separated by a 2 min wait and
2 min mix. Following the measurement of basal respiration, oligomycin (800 nM)
was injected into each well, followed by 3 cycles of; 2 min mix, 2 min wait and
3 min measurement to determine O2 consumption resulting from proton leak. The
difference between the basal OCR and the oligomycin-insensitive OCR yields the
amount of O2 consumption that is ATP-linked. The balance of the basal OCR is
comprised of O2 consumption due to proton leak and non-mitochondrial sources.
Then, FCCP (800 nM) was injected into each well, followed by 3 cycles of 2 min mix,
2 min wait and 3 min measurement to determine the maximal O2 consumption
that is possible at complex IV. The difference between FCCP rate and basal OCR
yields an estimate of the reserve capacity of the cells. Finally, antimycin A (200 nM)
was injected into each well, followed by 3 cycles of: 2 min mix, 2 min wait and
3 min measurement to determine the rate of O2 consumption from non-
mitochondrial sites.
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change in cell morphology or cell death rate (trypan blue extraction)
was observed in L6, H9c2 or HepG2 cells grown in galactose
compared with glucose (data not shown). In all three cell lines there
was a trend for higher growth rates in glucose than in galactose
media (Fig. 2A–C), reﬂected in increased doubling times for all three
cell types (Fig. 2D). Consequently, there were a signiﬁcantly greater
number of L6 cells after 24 and 48 h growth in glucose (Fig. 2E). A
slower growth rate in galactose media has been demonstrated with
HepG2 cells [7,9], skin ﬁbroblasts [15] and HeLa cells [33]. Slower
growth is partly due to the difference in uptake of galactose
compared with glucose since GLUT transporters have a higher
afﬁnity for glucose than galactose [38,19]. Galactose is also metabo-
lised at about an 8-fold slower speciﬁc rate than glucose, because
galactokinase, the rate-limiting step in galactose metabolism, is
considerably less active than hexokinase, the ﬁrst enzyme and
rate-limiting step in the oxidation of glucose [38]. Consequently,
the levels of glucose-6-phosphate, an important substrate essential
for cell proliferation via the pentose phosphate pathway (PPP)
production, are lower in galactose compared to glucose media
[7,39]. Therefore, in galactose media, the key PPP intermediates,
NADPH and ribose, are formed at a lower rate than in glucose media
and thus the growth rate is slower [38].
Previous studies have demonstrated that HepG2 and H9c2 cells
maintain equivalent levels of ATP when cultured in glucose or
galactose media [22,27]. Similarly, no signiﬁcant difference was
found in ATP content between L6 cells grown in glucose or
galactose media (Fig. 2F). This is also in agreement with studies
using human primary skeletal muscle cells, in which no difference
in the ATP content between myotubes cultured in high glucose
and galactose was found [1].
0 2 4 6 8 10 12 14 16 18 20 22 24
0
5
10
15
20
25
30
35
40
Glucose
Galactose
Time (days)
C
PD
0 1 2 3 4 5 6 7 8 9 10 11 12
0.0
0.5
1.0
1.5
2.0
2.5
3.0
3.5
4.0
4.5
5.0
5.5
6.0
Glucose
Galactose
Time (days)
C
PD
0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16
0
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
Glucose
Galactose
Time (days)
C
PD
L6 H9c2 HepG2
0
10
20
30
40
50
60
70
80
D
ou
bl
in
g 
Ti
m
e 
(H
ou
rs
)
Glucose
Galactose
24 48
0
5.0×105
1.0×106
1.5×106
2.0×106
2.5×106
3.0×106
3.5×106
Glucose
Galactose
* * * *
* * * *
Time (hours)
C
el
l n
um
be
r
Glucose Galactose
0
5.0×105
1.0×106
1.5×106
2.0×106
A
TP
Le
ve
l/2
0,
00
0c
el
ls
(L
um
in
es
ce
nc
ea
rb
itr
ar
yu
ni
t)
Fig. 2. Effect of replacing glucose with galactose on cell growth and ATP content. Growth curves plotted as cumulative population doubling (CPD) of L6 (A), H9c2 (B) and
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Sensitivity of cells grown in galactose to mitochondrial inhibition
Since cells grown on galactose rely mostly on mitochondrial
OXPHOS for their ATP synthesis they are reportedly more sensitive
to mitochondrial toxins than when grown in glucose [22,27].
This hypothesis was tested in glucose and galactose-grown L6,
H9c2 and HepG2 cells treated with rotenone (500 nM) or anti-
mycin A (AA; 150 nM), classical inhibitors of the mitochondrial
complex I and III, respectively. Effects on ATP content were used to
measure the susceptibility of the cells to OXPHOS inhibition.
In all three cell types grown on glucose media, ATP concentrations
were reduced to approximately 40–55% of control following culture
with AA for 24 h (Fig. 3A). In contrast, all cell types grown in
galactose were more highly susceptible and ATP levels were depleted
to o6% of control values. As further conﬁrmation that the L6 cells
had adapted to galactose, rotenone reduced ATP levels of L6 and
HepG2 cells to 1% of control values compared to glucose-grown cells
which maintained ATP levels at 35–48% of the control (Fig. 3B).
It should be noted that from these experiments it is not
possible to determine whether ATP is depleted due to a reduction
in the generation of ATP or whether an increase in the rate of cell
death also played a role. To determine the temporal relationship
between ATP level and cell death, a time course measuring ATP
levels and cell death markers (such as Annexin V/PI) would have to
be carried out. However, these results still indicated that in the
presence of galactose these three cell lines were more sensitive to
ETC inhibitors than in glucose. We therefore carried out AA dose
responses for each cell line in either glucose or galactose contain-
ing media (Fig. 4). The AA IC50 values differed considerably
between each cell line in both glucose and galactose media. All
three cell types showed increased sensitivity to AA when grown
on galactose media (Fig. 4A–C). The differential effect based on the
IC50 ratio of glucose to galactose, ranged from 5.9 (L6) to 17.7
(HepG2) and on the basis of ATP levels, clearly demonstrates that
on galactose, OXPHOS is the predominant source of ATP. It there-
fore serves as an ideal early screening assay to identify compounds
that may potentially induce mitochondrial toxicity. The variation
in glucose/galactose IC50 also shows that some cell types are more
sensitive to inhibitors of oxidative phosphorylation. Thus, the cell
type employed may be an important factor in the sensitivity of
the assay when using an IC50 ratio to investigate mitochondrial
perturbation. Therefore, more research using a number of cell
types and mitochondrial toxicants is required to ascertain the
importance of cell type.
It should be noted that not all the effects of mitochondrial
toxicants will be detected using a 24 h toxicity assay, as was used
here. While this assay may be able to accurately detect compounds
that inhibit the ETC (thiazolidinediones), uncouple OXPHOS (bupi-
vacaine) and redox cycle (quinones) within the mitochondria, it is
unlikely to detect compounds that target mtDNA replication
(NRTIs) and gene expression, which may need longer exposure
times [5,11,26].
Bioenergetics of L6 cells grown in galactose
Having demonstrated that L6 cells were more sensitive to AA in
galactose media we next characterised the bioenergetic status of
these cells using a seahorse extracellular ﬂux (XF) analyser. In this
system mitochondrial respiration (OCR) is used to measure
OXPHOS and extracellular acidiﬁcation (ECAR) as a measure of
glycolysis [14].
Consistent with previous studies on other cell types [29,15], we
found that L6 cells grown in glucose derived ATP from both
aerobic glycolysis and mitochondrial glutamine and pyruvate
oxidation (Fig. 5A and B). However, when L6 cells were cultured
in galactose, OXPHOS levels increased by at least 50% and basal
ECAR activity was 25% lower than in glucose cultured cells
(Fig. 5B and D). This is consistent with the fact that galactose
metabolism is unable to derive sufﬁcient ATP from glycolysis,
forcing the cells to rely almost exclusively on mitochondrial
OXPHOS (via glutamine and pyruvate oxidation) to produce ATP
[29,30,33]. The response of ECAR (glycolytic rate) in each media
type to mitochondrial toxicants provided detail on the mechanism
of increased galactose cell sensitivity after mitochondrial pertur-
bation (Fig. 5C and D). Following oligomycin treatment, mitochon-
drial ATP synthesis is blocked and glucose cultured cells were able
to up regulate glycolysis to meet their demand for ATP. However,
galactose cultured cells were unable to up regulate glycolysis and
so ECAR remained unchanged. The treatment with FCCP and AA
demonstrated that the majority of ECAR measured in galactose
cultured cells is derived from a small ‘proton leak’ from the
respiring mitochondria [31]. The uncoupling of the electron
transport chain by FCCP results in an increase in proton leak
across the inner mitochondrial membrane, which accounts for
the sharp increase of ECAR in the galactose cultured cells (Fig. 5C).
The inhibition of the ETC by AA severely depleted galactose cell
ECAR, but had no effect on glucose cell ECAR. This further conﬁrms
that glucose cultured cells are able to stimulate glycolytic ﬂux
following mitochondrial stress to provide the requisite ATP
for survival, while galactose cultured cells are unable to and
consequently die following mitochondrial perturbation [22].
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Effect of galactose on mitochondrial function in L6 cells
Similar to previous reports [10,28] mitochondrial function of L6
cells cultured in glucose and galactose media was deﬁned by
sequentially adding mitochondrial inhibitors to delineate the
components of the respiratory chain. As shown in Fig. 6, basal
OCR, proton leak, ATP-linked OCR and maximal OCR were sig-
niﬁcantly higher in galactose than in glucose cultured cells. In
contrast, the reserve capacity of cells grown in glucose was
signiﬁcantly greater than for galactose. Cells in galactose media
were unable to maintain maximal OCR levels following the
addition of FCCP, with the OCR decreasing to basal levels prior to
AA treatment (50–70 min; Fig. 5A). This implies that at basal
levels, the galactose cultured cells were operating closer to
maximal OCR capacity and any increase was unsustainable, result-
ing in a lower reserve capacity. There was also a trend for a higher
non-mitochondrial OCR in galactose cultured cells compared to
glucose cultured cells, but this did not reach statistical signiﬁcance.
The parameters of mitochondrial function were used to derive
the respiratory ﬂux control ratios, coupling efﬁciency, respiratory
control ratio (RCR), Stateapparent and phosphorylating respiration
(Table 1). The advantage of the ﬂux control ratios is that they are
internally normalised allowing for accurate comparison between
glucose and galactose cultured cells [4]. Table 1 shows there was
no signiﬁcant difference in coupling efﬁciency between glucose
and galactose cultured cells, indicating that sugar substrate change
had no effect on the efﬁciency of mitochondrial respiration
(Table 1). In both glucose and galactose media, 66% of cellular
OCR was related to ATP synthesis. The coupling efﬁciency of rat
skeletal muscle mitochondria has been shown to be 65% [32],
which is very similar to what was obtained with L6 cells cultured
in glucose and galactose media. RCR was signiﬁcantly greater in
glucose than galactose cultured cells (Table 1), which means the
mitochondria of glucose cultured cells have a greater potential for
substrate oxidation and ATP turnover than galactose cultured cells.
In addition, a higher RCR in glucose cultured cells correlates with
the lower proton leak seen in this study [4]. As with reserve
capacity, the lower RCR of cells cultured in galactose is attributable
to the fact that the basal OCR level of galactose cultured cells is
close to the maximal OCR capacity of the cells.
Taken together, these results show that the mitochondria of
galactose cultured cells were operating at a higher level of
respiration at basal levels than glucose cells and so were closer
to ‘state 3’ conﬁguration. This was not due to an increased
efﬁciency of the mitochondrial ETC however, implying a change
in OXPHOS complex synthesis or activity regulation. The reason for
an increased mitochondrial OCR in L6 cells grown in galactose
media compared to glucose media was not investigated in this
study. It has been shown that substrate oxidation correlates with
an increased respiratory ﬂux and is thereby responsible for
changes in state3u [4]. Possible explanations for an increased
substrate oxidation include a general increase in mitochondrial
content (through mitochondrial biogenesis), an increased synth-
esis of electron-transport chain complexes, an increase in proces-
sing enzymes, an increased ﬂux of glutamine oxidation through
the TCA cycle and ETC or a combination of each [33]. For example,
complex IV activity was found to be increased in primary human
muscle cells in galactose cultured cells, although there was no
increase in mitochondrial content [1]. In contrast, it has been
shown that HepG2 cells increase their mitochondrial content
through mitochondrial biogenesis in response to galactose media
[9]. Thus, each cell line/primary cell adapts mitochondrial and
1 10 100 1000
0
20
40
60
80
100
120
[Antimycin A] nM
%
 A
TP
 C
on
tr
ol
Glucose Galactose
* ****
1 10 100 1000
0
20
40
60
80
100
120
140
[Antimycin A] nM
%
 o
f A
TP
 C
on
tr
ol
***
1 10 100 1000
0
20
40
60
80
100
120
[Antimycin A] nM
%
 o
f A
TP
 C
on
tr
ol * **** IC50 (nM) IC50 Ratio
Cell Line Glucose 
media
Galactose 
media
Fold 
Difference
L6 42.1 7.1 5.9
H9c2 176.5 16.5 10.7
HepG2 58.1 3.3 17.7
Fig. 4. Antimycin A dose responses at 24 h for high-glucose (25 mM) and galactose-grown (10 mM) L6 (A), H9c2 (B) and HepG2 (C) cells treated with Antimycin A. Data are
mean7SEM; n¼4–5 (nnnPo0.001, nnnnPo0.0001 glucose vs. galactose). (D) IC50 values of L6, H9c2 and HepG2 treated with AA in glucose and galactose media was
calculated using a nonlinear regression. Maximum (DMSO control) and minimum values (total cell kill) were ﬁxed. The IC50 ratio was calculated by dividing the glucose IC50
by the galactose IC50.
W. Dott et al. / Redox Biology 2 (2014) 224–233 229
bioenergetic capabilities differently to galactose media and so
further research would be required to understand the mechanism
of adaptation of L6 cells to galactose media.
Effect of galactose on mitochondrial membrane potential and
superoxide generation
State 3u is characterised by a decrease in the protonmotive
force (Δp), an increase in proton leak and an acceleration of
electron transport [4]. The Δp describes the movement of protons
against their electrochemical gradient into the mitochondrial
inner membrane space, and has two components, ΔpH (the pH
gradient across the inner membrane) and ΔΨm (mitochondrial
membrane potential) [8]. As the dominant component, ΔΨm
contributes 80–85% to the Δp, and hence it is an important
measure of how the mitochondria are functioning [13,36]. The
ΔΨm of L6 cells cultured in glucose and galactose media was
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Table 1
Normalised respiratory ﬂux control ratios of L6 cells cultured in glucose and
galactose. The respiratory control ratio (RCR), coupling efﬁciency, Stateapparent and
phosphorylating respiration were derived from the mitochondrial parameters
shown in Fig. 6. Data represents mean7SEM; n¼5.
Normalised respiratory ﬂux control ratios L6 cells
Glucose Galactose
Stateapparent 3.3770.03 3.1970.03n
Respiratory control ratio (RCR) 4.2670.36 3.4370.19nn
Phosphorylating respiration 0.4770.01 0.5770.02n
Coupling efﬁciency 0.6670.02 0.6670.02
Stateapparent was calculated to determine the apparent respiratory rate in glucose
and galactose cells to provide an estimate of the relative mitochondrial work being
used by the cells under basal conditions. The galactose cells Stateapparent (3.19) was
signiﬁcantly closer to state 3 than glucose cells (3.37) were, indicating that
galactose cells had an increased mitochondrial workload compared to glucose
cells. In addition, the phosphorylating respiration of galactose cells (0.57) was
signiﬁcantly higher than glucose cells (0.47), demonstrating that galactose cells use
a greater proportion of the maximal respiratory capacity (maximal OCR) for ATP
production than glucose cells under basal conditions.
n Po0.05.
nn Po0.01 glucose vs. galactose.
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assessed using MitoTracker Red CMXRos. As shown in Fig. 7A, the
ΔΨm of L6 cells cultured in galactose media was 10% lower than
cells cultured in glucose media. Since galactose cultured cells had a
lower ΔΨm and a higher proton leak than glucose cultured cells,
this supports the suggestion that galactose cultured cells were
operating closer to state 3u than glucose cultured cells. To achieve
net forward ﬂux through each electron transport component a
thermodynamic disequilibrium is required, i.e. the free energy
available from electron transfer must be greater than that required
to pump protons across the membrane against the Δp [4]. Thus,
the electron transport chain responds to a drop in Δp, resulting
from an increased proton re-entry through the ATP synthase or
proton leak, with an increased ﬂux. Therefore, in galactose grown
cells, the decrease in Δp (as shown by the decrease in ΔΨm),
increase in proton leak and increase in ATP-linked OCR compared
to glucose grown cells, is indicative of an accelerated electron
transport ﬂux, and subsequent increase in ATP production via
mitochondrial OXPHOS.
The ΔΨm functions as a regulator of mitochondrial superoxide
production [36] and so the effect of culturing L6 cells in glucose and
galactose media on mitochondrial O2d– production was assessed
using MitoSox. Under basal conditions, glucose-cultured cells pro-
duced a signiﬁcantly greater amount of mitochondrial O2d– (18%
greater) than galactose cells (Fig. 7B). Cells with an increased
capacity for oxidative phosphorylation are also susceptible to
increased mitochondrial O2d– production through increased leakage
of electrons from the electron transport chain [4]. The function of
proton leak is therefore to provide cells with a greater degree of
protection from O2d–production via increased ‘mild uncoupling’ to
prevent mitochondrial O2d– production without deleteriously low-
ering ATP synthesis [8]. As such, mitochondrial O2d– production is
steeply dependent on Δp. The increased proton leak and subse-
quent decrease in ΔΨm of galactose cultured cells compared to
glucose cultured cells therefore explains why galactose cells had a
lower basal level of mitochondrial O2d– production than glucose
cells. A signiﬁcant increase in proton leak might be explained by a
difference in membrane composition or as the consequence of an
increase in the expression of proteins involved in matrix return of
protons. Basal proton conductance is primarily attributable to the
abundance of adenine nucleotide translocase (ANT), although
inducible proton conductance is catalysed by mitochondrial uncou-
pling proteins (UCPs) [8]. Notably, the mitochondrial anion carriers
UCP2 and UCP3 have been shown to protect against oxidative
damage by uncoupling when activated, thereby lowering Δp to
reduce the O2d– production [3].
Sensitivity of L6 cells cultured in glucose and galactose media to
antimycin A inhibition of OCR
The sensitivity of L6 cells cultured in glucose and galactose
media to complex III inhibition was investigated in a dose and
time dependent manner. In these experiments, a mitochondrial
function assay was performed on cells cultured in either glucose or
galactose with a range of AA concentrations to assess the OCR and
ECAR levels with each media type. The results are presented as a
percentage of baseline and since glucose cultured cells were able
to maintain an increased OCR following FCCP treatment, the
glucose control (DMSO) value is greater than galactose cultured
control when compared to baseline values (Fig. 8A and C). At all
concentrations tested, the effects of AA on OCR were identical in
each media type, suggesting that the threshold for complex III
inhibition was not different between L6 cells cultured in glucose
(Fig. 8A) and galactose (Fig. 8C) media. This is in line with research
in HeLa, ﬁbroblast and primary muscle cells that have shown no
difference in the level of complex III in glucose and galactose
cultured cells [33,25,1]. Rossignol et al. [33] suggest that high
amounts of complex III in glucose cells are required even when
there is little or no OXPHOS for other electron transport reactions
or biosynthetic needs. For example, a study by Ma et al. [21]
showed that complex III plays an important role in mediating
autophagy induction in a human glioblastoma H4 cell. Thus, if the
levels of complex III were equivalent in glucose and galactose-
grown L6 cells, this would explain why the rate of AA-induced OCR
decrease was identical in both cell types. In contrast to the effects
on OCR, the effects of AA on ECAR are different with each media
type (Fig. 8B and D). At the two highest concentrations of AA (40
and 80 nM), there is a 50% increase in ECAR with glucose
cultured cells, but a 50% reduction in ECAR with galactose
cultured cells. Therefore, these results conﬁrm what was found
in Fig. 5C and D, that L6 cells cultured in galactose are unable to
maintain glycolysis to support ATP production. Overall, these
results indicate that the increased sensitivity of galactose cultured
cells to AA is not due to a greater decrease in OCR, but likely a
Glucose Galactose
0
10
20
30
40
50
60
70
80
90
* *
M
ito
Tr
ac
ke
r R
ed
 F
lu
or
es
en
ce
 (A
U
)
Glucose Galactose
0
10
20
30
40
*
M
ito
 S
ox
 F
lu
or
es
en
ce
 (A
U
)
Fig. 7. Effect of galactose on mitochondrial membrane potential and mitochondrial superoxide production. L6 cells were cultured in glucose (red) or galactose (blue) media for a
minimum of 7 days and mitochondrial membrane potential (A) and mitochondrial superoxide production (B) were determined at basal conditions. Bars represent mean7SEM;
n¼3 (nPo0.05, nnPo0.01 glucose vs. galactose). (For interpretation of the references to color in this ﬁgure legend, the reader is referred to the web version of this article.)
W. Dott et al. / Redox Biology 2 (2014) 224–233 231
difference in the response of ECAR and the subsequent levels of
ATP produced by glycolysis.
Conclusions
In this study, we have demonstrated that L6 cells, like HepG2
and H9c2 cells, are able to adapt to growth in a galactose media
model and are consequently more susceptible to mitochondrial
toxicants. Investigation into cellular bioenergetics showed that
galactose cultured L6 cells have a signiﬁcantly increased OXPHOS
capacity compared to glucose cultured cells. Unlike glucose cul-
tured cells, however, cells cultured in galactose were unable to up
regulate glycolysis (ECAR) and maintain sufﬁcient ATP levels
following the inhibition of OCR by mitochondrial toxicants.
Further analysis into mitochondrial function revealed that galac-
tose cultured L6 cells operated closer to state 3 respiration and
consequently had a lower mitochondrial membrane potential and
basal mitochondrial O2d– level compared to glucose cultured cells.
In addition, an AA dose response revealed that there was no
difference in the sensitivity of OCR to AA inhibition between
glucose and galactose cultured cells. In contrast, glucose cultured
cells were able to up regulate ECAR, while galactose cultured cells
could not. Thus, we conﬁrm the current understanding that
galactose cell sensitivity is governed by its inability to up regulate
glycolysis to produce requisite ATP for survival. Overall, these
results conﬁrm the potential utility of the L6 galactose media
model to more sensitively detect mitochondrial toxicants that may
manifest as myotoxicity in vivo. Thus, the application of this high-
throughput L6 galactose media model early in the R&D process
may serve as an important screening assay for mitochondrial
toxicants that induce myotoxicity. However, more research is still
needed with known mitochondrial toxicants to validate the
importance of using tissue-speciﬁc cell lines when investigating
potential target-organ toxicities using the galactose media model.
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